Dermatology

Missed target failed trial trial failure

Pharma

InflaRx scraps vilobelimab study in rare skin disorder

After a poor showing of its COVID med vilobelimab in a rare skin disorder trial, German drugmaker InflaRx is going back to the drawing board.

Fraiser Kansteiner May 28, 2025 9:55am

sun protection hat sunscreen sunglasses beach

Almirall, Biofrontera kick off AK social media challenge

May 2, 2025 11:18am

Dr. Pimple Popper joins UCB hidradenitis suppurativa campaign

Apr 24, 2025 12:46pm

doctor dermatologist hand eczema

Leo survey shows chronic hand eczema’s effects on patient lives

Apr 22, 2025 6:00am

Graphic of two hands shaking under a red and purple light

Ligand's Pelthos unit merges with Channel to launch Zelsuvmi

Apr 17, 2025 5:00pm

Incyte

Incyte posts mixed Opzelura results in prurigo nodularis

Mar 10, 2025 11:23am